Podchaser Logo
Home
135| Neuropsychology’s Role in Anti-Amyloid Therapies – A Conversation With Dr. Kevin Duff

135| Neuropsychology’s Role in Anti-Amyloid Therapies – A Conversation With Dr. Kevin Duff

Released Monday, 15th January 2024
Good episode? Give it some love!
135| Neuropsychology’s Role in Anti-Amyloid Therapies – A Conversation With Dr. Kevin Duff

135| Neuropsychology’s Role in Anti-Amyloid Therapies – A Conversation With Dr. Kevin Duff

135| Neuropsychology’s Role in Anti-Amyloid Therapies – A Conversation With Dr. Kevin Duff

135| Neuropsychology’s Role in Anti-Amyloid Therapies – A Conversation With Dr. Kevin Duff

Monday, 15th January 2024
Good episode? Give it some love!
Rate Episode

Today we give you a discussion with Dr. Kevin Duff about neuropsychologists’ role with respect to lecanemab and other antiamyloid therapies.

Show notes are available at www.NavNeuro.com/135

_________________

If you’d like to support the show, here are a few easy ways:

1) Get APA-approved CE credits for listening to select episodes: www.NavNeuro.com/INS 

2) Tell your friends and colleagues about it

3) Subscribe (free) and leave an Apple Podcasts rating/review: www.NavNeuro.com/itunes

4) Check out our book Becoming a Neuropsychologist, and leave it an Amazon rating

 

Thanks for listening, and join us next time as we continue to navigate the brain and behavior!

[Note: This podcast and all linked content is intended for general educational purposes only and does not constitute the practice of psychology or any other professional healthcare advice and services. No professional relationship is formed between hosts and listeners. All content is to be used at listeners’ own risk. Users should always seek appropriate medical and psychological care from their licensed healthcare provider.]

Show More

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features